Indication
Staphylococcal pneumonia
Staphylococcal pneumonia is an acute, severe lower respiratory tract infection primarily caused by *Staphylococcus aureus*, involving either methicillin-susceptible or methicillin-resistant strains. Read more about Staphylococcal pneumonia
495 drugs 150 manufacturers
Drugs that treat it
Common Staphylococcal pneumonia therapies.
CLINDAMYCIN HCL
LEVOFLOXACIN
CLINDAMYCIN HCL
LEVOFLOXACIN
LINEZOLID
LEVOFLOXACIN
LINEZOLID
CLINDAMYCIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonStaphylococcal pneumonia is an acute, severe lower respiratory tract infection primarily caused by *Staphylococcus aureus*, involving either methicillin-susceptible or methicillin-resistant strains.
It affects pediatric, elderly, and immunocompromised individuals in community settings—frequently manifesting as a secondary infection following viral respiratory illnesses such as influenza—as well as hospitalized and mechanically ventilated patients.
Pathophysiologically, bacterial virulence factors, including cytotoxins and tissue-destructive enzymes, drive intense alveolar inflammation that can rapidly progress to tissue necrosis.
Clinically, it presents with high fever, cough, dyspnea, and purulent sputum, and it carries a high risk of aggressive complications such as cavitary or necrotizing pneumonia, pneumatoceles, empyema, and rapid deterioration into septic shock.
- nih.gov
Staphylococcal pneumonia is an acute, severe lower respiratory tract infection primarily caused by *Staphylococcus aureus*, involving either methicillin-susceptible or methicillin-resistant strains It affects pediatric, elderly, and immunocompromised individuals in community settings—frequently manifesting as a secondary infection following viral respiratory illnesses such as influenza—as well as hospitalized and mechanically ventilated patients Clinically, it presents with high fever, cough, dy...
- cdc.gov
Staphylococcal pneumonia is an acute, severe lower respiratory tract infection primarily caused by *Staphylococcus aureus*, involving either methicillin-susceptible or methicillin-resistant strains
- mdsearchlight.com
It affects pediatric, elderly, and immunocompromised individuals in community settings—frequently manifesting as a secondary infection following viral respiratory illnesses such as influenza—as well as hospitalized and mechanically ventilated patients
- nih.gov
Pathophysiologically, bacterial virulence factors, including cytotoxins and tissue-destructive enzymes, drive intense alveolar inflammation that can rapidly progress to tissue necrosis
- nih.gov
Pathophysiologically, bacterial virulence factors, including cytotoxins and tissue-destructive enzymes, drive intense alveolar inflammation that can rapidly progress to tissue necrosis
- rarediseases.org
Pathophysiologically, bacterial virulence factors, including cytotoxins and tissue-destructive enzymes, drive intense alveolar inflammation that can rapidly progress to tissue necrosis Clinically, it presents with high fever, cough, dyspnea, and purulent sputum, and it carries a high risk of aggressive complications such as cavitary or necrotizing pneumonia, pneumatoceles, empyema, and rapid deterioration into septic shock
- oup.com
Clinically, it presents with high fever, cough, dyspnea, and purulent sputum, and it carries a high risk of aggressive complications such as cavitary or necrotizing pneumonia, pneumatoceles, empyema, and rapid deterioration into septic shock
Personalize your experience
Follow Staphylococcal pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.